Suchergebnisse
Take-Two Set to Report Q1 Earnings: What's in the Cards for the Stock?
Take-Two Interactive Software TTWO is scheduled to report its first-quarter fiscal 2027 results on Aug. 7, 2026.For the first quarter of fiscal 2027, Take-Two expects GAAP net revenues between $1.45
Can Coca-Cola's Raised 2026 Outlook Support More Earnings Growth?
The Coca-Cola Company KO followed a better-than-expected second quarter by raising its fiscal 2026 outlook. Higher volume, margin expansion and currency benefits strengthened the earnings picture
Can FEMSA's Q2 Momentum Offset Margin Pressure Across Its Portfolio?
Fomento Económico Mexicano, S.A.B. de C.V. FMX, or FEMSA, topped second-quarter earnings and revenue expectations as OXXO Mexico and Coca-Cola FEMSA delivered solid growth. Net income and adjusted
Argan Acquires ValCor to Strengthen New England Presence
Argan, Inc. AGX has expanded its Teledata operations into New England through the acquisition of Connecticut-based ValCor Communications by its wholly owned subsidiary, Southern Maryland Cable Inc
Should Investors Buy ADTN or Wait for Better Execution Signals?
ADTRAN Holdings, Inc. ADTN continues to benefit from favorable long-term networking trends, but near-term execution challenges have made the investment case less straightforward. Investors must
Is Conagra Stock Worth Buying as Low Valuation Meets Weak Growth?
Conagra Brands, Inc. CAG presents a difficult value decision. The stock’s discounted forward earnings multiple offers a measure of downside support, but fiscal 2027 guidance points to lower sales
Large-cap Growth ETF (VOOG) Hits New 52-Week High
Vanguard S&P 500 Growth Index Fund ETF Shares VOOG is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 31.82% from its 52-week low price of
NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears
Key Points
- Interested in NewAmsterdam Pharma Company N.V.? Here are five stocks we like better.
- PREVAIL is the key near-term catalyst: NewAmsterdam expects to reach its interim event target by
Medline Q2 Earnings Call Highlights
Key Points
- Interested in Medline? Here are five stocks we like better.
- Medline reported strong second-quarter growth, with net sales up 12% to $7.7 billion, led by a 16% increase in Supply
Limbach Q2 Earnings Call Highlights
Key Points
- Interested in Limbach Holdings, Inc.? Here are five stocks we like better.
- Second-quarter profitability weakened despite revenue rising 22% to $173.5 million, as gross margin fell to
LivaNova Q2 Earnings Call Highlights
Key Points
- Interested in LivaNova PLC? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 9.8% year over year on a constant-currency basis to $391 million, while adjusted
Lineage Q2 Earnings Call Highlights
Key Points
- Interested in Lineage, Inc.? Here are five stocks we like better.
- Second-quarter results exceeded expectations: Adjusted EBITDA was approximately $320 million and AFFO was $198
Kymera Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Kymera Therapeutics, Inc.? Here are five stocks we like better.
- KT-621 atopic dermatitis trial enrollment is complete about six months ahead of schedule, with top-line
J & J Snack Foods Q3 Earnings Call Highlights
Key Points
- Interested in J & J Snack Foods Corp.? Here are five stocks we like better.
- Fiscal Q3 results weakened: Net sales fell 6.2% to $426 million, adjusted EBITDA declined 6.4% to $67.4
Interparfums Q2 Earnings Call Highlights
Key Points
- Interested in Interparfums, Inc.? Here are five stocks we like better.
- Interparfums maintained its 2026 outlook for approximately $1.48 billion in sales and diluted EPS of $4.85
CorVel Q1 Earnings Call Highlights
Key Points
- Interested in CorVel Corp.? Here are five stocks we like better.
- CorVel reported strong fiscal first-quarter results: Revenue rose 11% year over year to $260 million, EPS increased
Avnet Q4 Earnings Call Highlights
Key Points
- Interested in Avnet, Inc.? Here are five stocks we like better.
- Record fourth-quarter results: Avnet reported fiscal 2026 Q4 sales of $8.3 billion, up 48% year over year, and
Can ViaSat-3 Launches Unlock Viasat's Next Growth Phase?
The next phase of Viasat's VSAT ViaSat-3 constellation marks one of the company's most important operational milestones. As additional satellites move closer to commercial service, investors are
TPG RE Finance Trust Q2 Earnings Call Highlights
TPG RE Finance Trust Q2 Earnings Call Highlights
Can BigBear.ai Lead the Multi-Drone Mission AI Solutions Market?
BigBear.ai Holdings, Inc. BBAI is positioning itself to become a key player in AI-powered autonomous mission management, with multi-drone orchestration emerging as one of its most promising growth


